Parambir S Dulai

50PUBLICATIONS
138CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityBusiness information management (incl. records, knowledge and intelligence)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (50)

|Sep 23, 2026
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy.

|Jul 15, 2026
Butyrate epigenetically licenses sustained epithelial-T cell crosstalk for intestinal immune tolerance.

|Jun 01, 2026
Advanced therapy treatment patterns in moderate-to-severe ulcerative colitis: a long-term retrospective claims analysis.

|May 28, 2026
A decade of clinical data with vedolizumab: the past, present, and future.

|May 12, 2026
Vedolizumab clinical decision support tool predicts clinically relevant targets in patients with Crohn's disease.

|Apr 28, 2026
Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials.

Pageof 9

Frequent Collaborators

14 joint publications

William Sandborn

14 joint publications

Siddharth Singh

14 joint publications

Neeraj Narula

8 joint publications

Brian G Feagan